1. Dramatic response of an inoperable Merkel cell carcinoma with imatinib
Cecile Frenard, MD, Lucie Peuvrel, MD, Anabelle Brocard, MD, Melanie Saint-Jean, MD, Anne Moreau, MD, Brigitte Dreno, PhD, Gaelle Quéreux, PhD 
JAAD Case Reports 
Volume 2, Issue 1, Pages (January 2016)
DOI: /j.jdcr
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Evolution of the tumor. A, Large firm tumor of the left eyebrow and impossible palpebral aperture. B, After 4 months of treatment with imatinib, complete clinical remission of the tumor.
JAAD Case Reports 2016 2, 16-18DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Facial CT scan examination before treatment and after 20 months of imatinib. A, Voluminous mass with intraorbital extension before treatment. B, Complete remission of the tumor after 20 months of imatinib.
JAAD Case Reports 2016 2, 16-18DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions